You have 9 free searches left this month | for more free features.

sepsis, glucocorticoid

Showing 1 - 25 of 2,476

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sepsis Trial (Metformin)

Not yet recruiting
  • Sepsis
  • (no location specified)
Aug 6, 2023

Sepsis Trial in Seongnam-si, Seoul (Dexamethasone)

Recruiting
  • Sepsis
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +1 more
Jan 10, 2022

Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA) Trial in Worldwide (IFX-1, Placebo-IFX-1, Glucocorticoid

Completed
  • Granulomatosis With Polyangiitis (GPA)
  • Microscopic Polyangiitis (MPA)
  • Leuven, Belgium
  • +75 more
Aug 3, 2022

Intestinal Obstruction and Ileus, Perforated Viscus, Sepsis Trial in Hvidovre (Dexamethasone 1 mg/kg, Physiologic saline)

Recruiting
  • Intestinal Obstruction and Ileus
  • +4 more
  • Dexamethasone 1 mg/kg
  • Physiologic saline
  • Hvidovre, Denmark
    Mirjana Cihoric
Mar 27, 2022

Solid Tumors Trial in United States (CORT125134 with nab-paclitaxel)

Completed
  • Solid Tumors
  • Relacorilant with nab-paclitaxel
  • Scottsdale, Arizona
  • +3 more
Nov 9, 2022

Complication Trial in Dongguan, Guangzhou (autologous cord blood mononuclear cells, normal saline)

Recruiting
  • Complication
  • autologous cord blood mononuclear cells
  • normal saline
  • Dongguan, Guangdong, China
  • +1 more
Oct 9, 2021

Acute Respiratory Distress Syndrome Trial in China (device, behavioral, drug, other, biological, combination product, genetic)

Recruiting
  • Acute Respiratory Distress Syndrome
  • protective ventilation
  • +13 more
  • Beijing, China
  • +10 more
Dec 13, 2022

Sepsis, Severe, Septic Shock Trial in Lakewood, Toms River (Ascorbic Acid, Thiamine, Hydrocortisone)

Completed
  • Sepsis, Severe
  • Septic Shock
  • Ascorbic Acid
  • +3 more
  • Lakewood, New Jersey
  • +1 more
Aug 25, 2021

Graves Ophthalmopathy Trial in Sofia (Methylprednisolone)

Completed
  • Graves Ophthalmopathy
  • Sofia, Bulgaria
    University Hospital of Endocrinology
Mar 29, 2023

Lupus Erythematosus, Systemic Trial in Worldwide (Placebo, Ustekinumab (approximately 6 mg/kg), Ustekinumab 90 mg)

Terminated
  • Lupus Erythematosus, Systemic
  • Placebo
  • +2 more
  • Anniston, Alabama
  • +203 more
Jan 31, 2023

Knee Osteoarthritis Trial (Sinomenine, Glucocorticoid)

Not yet recruiting
  • Knee Osteoarthritis
  • (no location specified)
Mar 1, 2023

Healthy Trial in Aarhus (Prednisolone)

Recruiting
  • Healthy
  • Aarhus, State, Denmark
    Department of Endocrinology and Internal Medicine
Sep 6, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer AJCC v8 Trial in San Francisco

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • San Francisco, California
    University of California San Francisco
Dec 19, 2022

Reduced-dose Alemtuzumab for Kidney Transplant Rejection

Not yet recruiting
  • Kidney Transplant Rejection
    • (no location specified)
    Oct 25, 2023

    Registration of Sepsis Patients in the Emergency Department

    Not yet recruiting
    • Sepsis
    • no intervention
    • (no location specified)
    Sep 28, 2023

    Inflammatory Cardiomyopathy, Myocarditis Trial in Wuhan (Hydroxychloroquine, Prednisolone)

    Recruiting
    • Inflammatory Cardiomyopathy
    • Myocarditis
    • Wuhan, Hubei, China
      Tongji Hospital
    Jul 18, 2023

    IgG4-related Disease With Eosinophilia Trial in Beijing (Prednisolone, Baricitinib)

    Recruiting
    • IgG4-related Disease With Eosinophilia
    • Beijing, Bejing, China
      Peking Union Medical College Hospital
    Mar 23, 2023

    Giant Cell Arteritis Trial (Secukinumab 300 mg, s.c., Placebo to match Secukinumab, s.c.)

    Recruiting
    • Giant Cell Arteritis
    • Secukinumab 300 mg, s.c.
    • Placebo to match Secukinumab, s.c.
    • Berlin, Germany
    • +2 more
    Oct 12, 2022

    HO-1/CREB3 Modulates Golgi Stress in Patients With Sepsis

    Not yet recruiting
    • Sepsis
    • nothing
    • Tianjin, Tianjin, China
      Tianjin Nankai Hospital
    Sep 13, 2023

    Sepsis in ICU:Causes and Outcomes in Diabetics and Non Diabetics

    Not yet recruiting
    • Sepsis
    • PCR for legionella ,blood ,urine cultures and from catheters or source of infection
    • (no location specified)
    Jun 22, 2023

    Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])

    Not yet recruiting
    • Immune Thrombocytopenia
    • Treatment
    • Obinutuzumab Injection [Gazyva]
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital, Chinese Aca
    Oct 17, 2023

    rTEM in the Prognosis and Severity of Sepsis Induced ARDS

    Not yet recruiting
    • Sepsis
    • Taking peripheral blood
    • (no location specified)
    Oct 1, 2023

    Sepsis Trial in Shanghai (Shen-Fu, Norepinephrine (NE),antibiotics,fluid resuscitation)

    Recruiting
    • Sepsis
    • Shen-Fu
    • Norepinephrine (NE),antibiotics,fluid resuscitation
    • Shanghai, Shanghai, China
      Ruijin Hospital
    Nov 27, 2023

    Patients Admitted With Septic Shock in Intensive Care Unit

    Recruiting
    • Critical Illness
    • +2 more
    • Retrospective chart review
    • Al Ain, United Arab Emirates
      Tawam Hospital ICU
    Feb 14, 2023

    Sjogren Syndrome With Other Organ Involvement Trial (Prednisolone, Tacrolimus)

    Not yet recruiting
    • Sjogren Syndrome With Other Organ Involvement
    • (no location specified)
    Jan 12, 2023